The device is based on terahertz radiation, an electromagnetic range positioned between microwaves and infrared light. Terahertz waves can interact with collective molecular motions, weak intermolecular forces and other low-energy excitations that are difficult to observe using conventional optical methods. In principle, these interactions create spectral signatures that can distinguish one substance from another. Biological samples, however, are rarely clean or simple. They may contain proteins, nucleic acids, metabolites and other compounds at different concentrations, producing signals that overlap and complicate interpretation. A sensor capable of separating those contributions could offer a new route to biochemical analysis.

The researchers’ approach combines terahertz sensing with a metasurface, a deliberately engineered arrangement of subwavelength structures that manipulates electromagnetic fields. Rather than relying on the natural interaction between a weak terahertz beam and a tiny quantity of biomaterial, a metasurface can concentrate electromagnetic energy into localized regions near its surface. These “hot spots” increase the interaction between the incoming radiation and molecules captured or deposited in the sensing area. Even when the analyte layer is extremely thin, changes in the local environment can shift or reshape the metasurface’s resonant response, producing a measurable signal.

The “on-chip” aspect is equally important. Traditional terahertz systems often depend on bulky emitters, detectors, optical components and free-space alignment. Such arrangements are valuable in research laboratories but can be difficult to translate into instruments used at clinics, field stations or industrial facilities. Integrating the sensing architecture onto a chip aims to reduce the optical path, simplify packaging and make the system more compatible with electronic readout. In the longer term, this type of integration could support arrays containing many sensing elements, each optimized for a different target or measurement condition.

Quantitative multi-component identification is more demanding than conventional detection. A single target can sometimes be recognized by monitoring one characteristic spectral change. In a mixture, however, the measured response is a combination of several molecular contributions, the sensor’s own resonance behavior and variations caused by the sample environment. The problem resembles separating several voices recorded by one microphone. The device must generate sufficiently distinctive and reproducible signals, while the analysis must determine how much of each component contributed to the final response.

Metasensors address this problem by converting subtle molecular changes into larger shifts in electromagnetic behavior. When molecules bind to or accumulate near the engineered surface, they alter the local refractive index and can modify the amplitude, frequency or linewidth of a resonance. These changes can be measured in the terahertz domain and compared with calibration data or computational models. By examining multiple features rather than relying on a single signal, an algorithm can estimate the composition of a mixture. The approach is particularly relevant to biomolecular systems, where different compounds may be present at low concentrations and share similar chemical signatures.

One obstacle is water. Terahertz radiation is strongly absorbed by liquid water, and biological samples are commonly water-rich. This absorption can reduce the distance over which the radiation travels and obscure weak molecular signals. A practical terahertz biosensor therefore has to control the sample geometry, limit the effective optical path or use surface-bound molecules so that the measurement occurs close to the sensing interface. The on-chip metasurface architecture is designed around that constraint, concentrating the field where the biological material is located rather than depending on a long transmission path through a liquid sample.

The significance of the study lies in bringing several difficult requirements together: terahertz operation, electromagnetic enhancement, chip-scale integration and analysis of more than one biomolecular component. Each element addresses a separate limitation of established sensing technologies. Terahertz measurements can provide information unavailable from visible-light assays; metasurfaces can amplify weak interactions; on-chip construction can support miniaturization; and multi-component analysis moves beyond the one-target-at-a-time format of many biosensors. The combination could eventually be useful for complex samples in which the biological meaning depends on a profile rather than a single marker.

Such a platform could have implications for medical diagnostics, environmental monitoring, food safety and pharmaceutical manufacturing, although translation will depend on further validation. Real-world samples introduce challenges that controlled laboratory mixtures may not capture, including nonspecific adsorption, temperature fluctuations, changes in pH, uneven sample distribution and interference from abundant background molecules. Quantitative measurements also require rigorous calibration, reference standards and statistical methods capable of distinguishing genuine biochemical variation from sensor drift. Reproducibility across chips and batches will be essential if the technology is to move from a promising device concept to a dependable analytical tool.

The researchers’ work points toward a future in which a small chip could interrogate several biomolecular signals at once and deliver a compositional readout without requiring a large analytical instrument. That vision is not the same as an immediate replacement for established laboratory methods, but it represents a significant direction for terahertz photonics and biosensing. By engineering the interaction between light and matter at the chip surface, the technology seeks to make molecular information more accessible, more compact and more quantitative. If subsequent studies demonstrate robust performance in complex biological samples, on-chip terahertz metasensors could become an important building block for next-generation diagnostics and rapid chemical analysis.

Subject of Research: On-chip terahertz metasensor for quantitative multi-component biomolecular identification

Article Title: On-chip terahertz metasensor for quantitative multi-component biomolecular identification

Article References: Xu, X., Duan, H., Lu, Y. et al. On-chip terahertz metasensor for quantitative multi-component biomolecular identification. Light Sci Appl 15, 345 (2026). https://doi.org/10.1038/s41377-026-02427-x

Image Credits: AI Generated

DOI: 10.1038/s41377-026-02427-x

Keywords: terahertz metasensor, on-chip biosensing, biomolecular identification, multi-component analysis, metasurface, quantitative detection, terahertz photonics

At the heart of this breakthrough lies the ability to microfabricate complex three-dimensional structures on a microscopic scale, a feat challenging to achieve with conventional lithography or planar fabrication methods. The 3D micro-printed sensors offer a transformative platform capable of interfacing directly with biological environments at the cellular and molecular level. This spatial precision enables the detection of disease biomarkers with unparalleled accuracy while maintaining biocompatibility, essential for real-world diagnostic applications.

One of the most striking technological advances in this work is the integration of multiple sensing elements into a single microchip, leveraging precise spatial arrangement within a nanoscale framework. This spatial multiplexing allows simultaneous detection of various biomolecules, which significantly improves diagnostic throughput and reduces time-to-result. The sensors employ novel materials with tailored electrical and chemical properties to optimize signal transduction and stability during long-term operation.

The fabrication technique employed by the PolyU team revolves around direct laser writing and advanced two-photon polymerization processes. These methods harness femtosecond laser pulses to sculpt intricate 3D architectures within photosensitive resins, achieving resolutions far below the diffraction limit of light. This innovation not only enables miniaturization but also confers greater mechanical robustness, a critical factor for sensor durability under physiological conditions.

To enhance the biosensing capabilities, the sensor surfaces are functionalized with highly selective biorecognition elements such as antibodies, aptamers, and enzyme substrates. This biochemical modification ensures that the sensors respond selectively to target analytes, such as proteins or nucleic acids associated with early pathological states. This highly specific molecular recognition, combined with the sensor’s electronic transduction, allows for quantitative measurement of trace biomarkers in complex biological fluids.

Moreover, the sensor’s architecture is designed to optimize signal amplification through nanostructured electrode arrays. By increasing the active surface area and enhancing electron transfer kinetics, the system achieves remarkable sensitivity that can detect biomarkers at femtomolar concentrations. These sensing enhancements could significantly benefit early-stage disease screening, where biomarker concentrations are typically low and difficult to quantify reliably.

Importantly, the compact form factor and integrable design of these sensors facilitate seamless integration with microfluidic systems, paving the way for fully automated, lab-on-a-chip devices. Such integrated platforms can perform sample preparation, sensing, and data acquisition within a single device, streamlining the diagnostic workflow. This combination holds immense potential for point-of-care testing in resource-limited settings, eliminating the need for bulky instrumentation and reducing costs.

Beyond diagnostic applications, the 3D micro-printed sensor technology presents an adaptable framework for personalized medicine. Because the sensors can be custom-fabricated to target specific biomarkers unique to an individual’s disease profile, they offer a pathway toward tailored diagnostics and monitoring. This customization capability is vital in managing complex diseases, such as cancer or neurodegenerative disorders, where biomarker variability challenges conventional sensing techniques.

The durability and biocompatibility of these micro-printed sensors have also been rigorously tested, demonstrating their suitability for in vivo applications. The materials used resist degradation and maintain consistent performance in physiological environments, an attribute crucial for implantable or wearable biosensors. This robustness ensures reliable, repeated measurements, enabling continuous monitoring of patient health parameters.

PolyU’s innovation not only pushes the boundaries of sensor miniaturization but also opens vistas for interfacing electronics intimately with biological systems. The potential to capture real-time molecular information with high fidelity could transform fields beyond medicine, including environmental monitoring and security, where sensitive, rapid detection of chemical agents is needed. These versatile sensing platforms represent a convergence of multidisciplinary expertise that is reshaping the landscape of analytical technology.

Looking forward, the research team is exploring further enhancements, such as incorporating AI-driven data analysis and wireless communication modules directly onto the sensor chip. This fusion of advanced hardware and intelligent software aims to deliver smart diagnostic systems that provide actionable insights without human intervention. The modular nature of the sensors facilitates easy adaptation to emerging diagnostic challenges, promising a proactive approach to healthcare management.

With regulatory approval and clinical validation on the horizon, the commercialization potential of these 3D micro-printed sensors is immense. By significantly reducing detection times and improving the accuracy of early diagnosis, this technology aligns with global healthcare objectives of disease prevention and personalized treatment. PolyU’s pioneering work embodies the future of biotechnological innovation, making sophisticated diagnostics more accessible, efficient, and responsive to patient needs.

This revolutionary advance in on-chip biosensing heralds a new era in disease detection technology, showcasing the remarkable synergy between microfabrication, materials science, and biomedical engineering. As healthcare systems worldwide grapple with increasing demands for rapid, accurate diagnostics, these 3D micro-printed sensors may well become indispensable tools in the global fight against disease.

Subject of Research:
Development of 3D micro-printed biosensors for enhanced on-chip detection of disease biomarkers.

Article Title:
PolyU Researchers Pioneer 3D Micro-Printed Sensors to Advance On-Chip Biosensing for Early Disease Detection.

Image Credits:
Images courtesy of The Hong Kong Polytechnic University (PolyU).

Keywords:
3D micro-printing, biosensors, early disease detection, on-chip biosensing, microfabrication, lab-on-a-chip, two-photon polymerization, biomarker detection, personalized medicine, biorecognition elements, signal amplification, point-of-care diagnostics.